Human ALPP knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 17 bp deletion in exon 5
Products, services, reviews and techniques used in the preliminary investigations of the disease; the cell biology, genetics and protein pathways using tissue culture, cloning and imaging.
Knockout achieved by using CRISPR/Cas9, Homozygous: 17 bp deletion in exon 5
Knockout achieved by using CRISPR/Cas9, Homozygous: 10 bp deletion in exon 1
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 2 bp deletion in exon 3
Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2
Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 4
Knockout achieved by using CRISPR/Cas9, 182 bp deletion in exon 5 and 1 bp deletion in exon 5 and 4 bp deletion in exon 5
Knockout achieved by using CRISPR/Cas9, 67 bp insertion in exon 3 and Insertion of the selection cassette in exon 3
Knockout achieved by using CRISPR/Cas9, 11 bp deletion in exon 1 and 1 bp insertion in exon 1 and 4 bp deletion in exon 1
Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and Insertion of the selection cassette in exon 1
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and 2 bp insertion in exon 1